Menorrhagia in patients with type i glycogen storage disease

Obstetrics and Gynecology

Volumn 122, Issue 6, 2013, Pages 1246-1254

  Austin, Stephanie L ^a,b,c   El Gharbawy, Areeg H ^a,b,c   Kasturi, Vellore G ^a,b,c   James, Andra ^a,b,c   Kishnani, Priya S ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS NORGESTREL; HEMOGLOBIN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; ECCHYMOSIS; EMERGENCY CARE; EPISTAXIS; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERLACTATEMIA; HYPERLIPIDEMIA; HYPOTHYROIDISM; LIVER ADENOMA; MEDICAL RECORD REVIEW; MENORRHAGIA; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOMA; ADULT; ANEMIA; BLOOD GLUCOSE; FEMALE; GLYCOGEN STORAGE DISEASE TYPE I; HEMOGLOBINS; HORMONES; HUMANS; HYPERLIPIDEMIAS; LACTIC ACID; LIVER NEOPLASMS; MENORRHAGIA; MIDDLE AGED; PLATELET AGGREGATION; RETROSPECTIVE STUDIES; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84889245586     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000435451.86108.82     Document Type: Article

References (32)

1. Chen Y, Koeberl D, Kishnani P. Glycogen storage diseases. In: Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, Ballabio A, editors. The online metabolic and molecular basis of inherited disease. 8th ed. New York (NY):McGraw-Hill; 2009.
2. Chen YT, Bazzarre CH, Lee MM, Sidbury JB, Coleman RA. Type I glycogen storage disease: nine years of management with cornstarch. Eur J Pediatr 1993;152(Suppl 1):S56-9. (Pubitemid 23134780)
3. Fernandes J, Alaupovic P, Wit JM. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res 1989;25: 327-31. (Pubitemid 19099800)
4. Wolfsdorf JI, Crigler JF Jr. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. J Pediatr Gastroenterol Nutr 1999;29:136-43. (Pubitemid 30366162)
5. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161(Suppl 1):S20-34.
6. Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Clin Endocrinol (Oxf) 1995;42:601-6.
7. Lee PJ, Muiesan P, Heaton N. Successful pregnancy after combined renal-hepatic transplantation in glycogen storage disease type Ia. J Inherit Metab Dis 2004;27:537-8. (Pubitemid 39140146)
8. Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M, et al. Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol 2008;198:646 e1-7.
9. Czapek EE, Deykin D, Salzman EW. Platelet dysfunction in glycogen storage disease type I. Blood 1973;41:235-47.
10. Muhlhausen C, Schneppenheim R, Budde U, Merkel M, Muschol N, Ullrich K, et al. Decreased plasma concentration of von Willebrand factor antigen (VWF: Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis 2005;28: 945-50. (Pubitemid 43168931)
11. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss-a population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1966; 45:320-51.
12. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol 2004;190: 1216-23. (Pubitemid 38692200)
13. Roy CN, Weinstein DA, Andrews NC. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res 2003;53:507-12.
14. James AH. More than menorrhagia: a review of the obstetric and gynaecological manifestations of bleeding disorders. Haemophilia 2005;11:295-307. (Pubitemid 41030828)
15. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Guidelines for management of glycogen storage disease type I -European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161(Suppl 1):S112-119.
16. Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Lombardi G, et al. Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. J Pediatr 2007;150:300-5, 300.e1.
17. Fielding D, Duff A. Compliance with treatment protocols: interventions for children with chronic illness. Arch Dis Child 1999;80:196-200. (Pubitemid 29119740)
18. Edlund M, Blomback M, Fried G. Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time. Blood Coagul Fibrinolysis 2002;13:225-31. (Pubitemid 35001888)
19. Marti GE, Rick ME, Sidbury J, Gralnick HR. DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood 1986;68: 180-4. (Pubitemid 16033627)
20. Kishnani PS, Chuang TP, Bali D, Koeberl D, Austin S, Weinstein DA, et al. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. Hum Mol Genet 2009;18:4781-90.
21. Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr 2011;159:442-6.
22. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci 2006;1089:228-36. (Pubitemid 47092098)
23. Mairovitz V, Labrune P, Fernandez H, Audibert F, Frydman R. Contraception and pregnancy in women affected by glycogen storage diseases. Eur J Pediatr 2002;161(Suppl 1):S97-101.
24. Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, Dos Santos Fernandes AM, Lui-Filho JF, Perrotti M, et al. A prospective study of the forearm bone density of users of etonorgestrel-and levonorgestrel-releasing contraceptive implants. Hum Reprod 2006;21:466-70. (Pubitemid 43159924)
25. Wallwiener D, Rimbach S, Kaufmann M, Aydeniz B, Sohn C, Bastert G, et al. Hysteroscopic endometrium ablation in highrisk situations and in hemorrhagic diathesis [in German]. Zentralbl Gynäkol 1995;117:652-8.
26. Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding: a Cochrane review. Hum Reprod 2002;17:2795-806. (Pubitemid 35350893)
27. Rubin G, Wortman M, Kouides PA. Endometrial ablation for von Willebrand disease-related menorrhagia-experience with seven cases. Haemophilia 2004;10:477-82. (Pubitemid 39317757)
28. Huq FY, Al-Haderi M, Kadir RA. The outcome of endometrial ablation in women with inherited bleeding disorders. Haemophilia 2012;18:413-20.
29. Sechi A, Deroma L, Lapolla A, Paci S, Melis D, Burlina A, et al. Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. J Inherit Metab Dis 2012;36:83-9.
30. Elliott JL, Hosford SL, Demopoulos RI, Perloe M, Sills ES. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis. South Med J 2001;94: 529-31. (Pubitemid 33643489)
31. Ewies AA, Alfhaily F. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia. Obstet Gynecol Surv 2012;67:726-33.
32. El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, et al. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol 2007;109: 1381-7. (Pubitemid 46869878)